生物活性 | |||
---|---|---|---|
描述 | PK68, a potent and selective oral type II inhibitor of receptor-interacting kinase 1 (RIPK1) with an IC50 of ~90 nM, effectively inhibits RIPK1-dependent necroptosis. It significantly mitigates TNF-induced systemic inflammatory response syndrome and is applicable in studying inflammatory disorders and cancer metastasis [1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.36mL 0.47mL 0.24mL |
11.78mL 2.36mL 1.18mL |
23.56mL 4.71mL 2.36mL |
参考文献 |
---|